+39 06 99775399 info@reithera.com
Languages
  • Italiano
  • English
The first Ebola Sudan vaccine doses to reach Uganda manufactured at ReiThera LEARN MORE
  • Home
  • About
  • R&D
  • CDMO
  • News
    • Grants
    • Press Release
    • Publications
    • Events
  • Contact
  • English
    • Italian
An ideal partner for your biotechnological journey An ideal partner for your biotechnological journey
  • Home
  • About
  • R&D
  • CDMO
  • News
    • Grants
    • Press Release
    • Publications
    • Events
  • Contact
  • English
    • Italian

Archives

Monthly Archive for: "November, 2020"
November 2020
0
By ef
In News
Posted November 30, 2020

Vaccino anti Covid ReiThera, bene la prima fase sperimentata a Castel Romano

(Articolo tratto da Repubblica.it) E’ soltanto la fase 1 ma fa ben sperare la risposta del vaccino italiano anti-Covid di ReiThera in corso di sperimentazione a Roma e a Verona. La stessa [...]

READ MORE
0
By ef
In News, Press Release
Posted November 24, 2020

ReiThera Announces its GRAd-COV2 COVID-19 Vaccine Candidate is Well Tolerated and Induces Clear Immune Responses in Healthy Subjects Aged 18-55 Years Phase 1 Trial to Advance into Elderly Subjects Aged 65-85 Years

ROME, Italy, November 24th, 2020 – ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products [...]

READ MORE
Our privacy

Privacy Policy and Cookie Law

Modello Organizzativo 231

Follow us
  • linkedin
  • facebook
  • instagram
  • twitter

ReiThera srl is a biotech company developing products based on gene delivery technologies for advanced therapies, from early development to final QP release.

© Copyright 2018 | Made with by